Skip to content

Regenxbio RGNX Total Current Liabilities

Total Current Liabilities at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.11B+43.2%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$499.16M-17.6%
Biogen logo
BiogenBIIB
$3B-43.4%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$793.15M+26.3%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$37.46M-10.1%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$325M+11.4%

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total debt$71.1M-11.0%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Market cap$529.38M+24.6%
Enterprise value$585.22M+56.3%
P/S+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
Net margin-330.2%-588pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regenxbio's total current liabilities?
Regenxbio (RGNX) reported total current liabilities of $71.11M in Q1 2026.
How has Regenxbio's total current liabilities changed year-over-year?
Regenxbio's total current liabilities decreased by 33.4% year-over-year, from $106.73M to $71.11M.
What is the long-term trend for Regenxbio's total current liabilities?
Over 5 years (2020 to 2025), Regenxbio's total current liabilities has grown at a 7.7% compound annual growth rate (CAGR), from $81.45M to $118.1M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.